Archive
All News
Every briefing, headline, and filing we've published, newest first.
The WeekBioPharma Dive ↗
Sionna's medicine didn't have a meaningful additive impact when combined with Vertex's top-selling Trikafta, s…
The WeekPharmaVoice ↗
While a disappointing late-stage readout sent biotech stocks tumbling, all hope may not be lost for the emergi…
The WeekFiercePharma ↗
AbbVie retook the top spot from rival J&J and its immunology drug Tremfya in July's top TV drug ad spendin…
The WeekFierceBiotech ↗
Arpeggio Biosciences' eight-year song has come to an end as the transcriptome biotech's CEO admitted the compa…
The WeekBriefing
Replimune secured FDA approval for Tudriqev after two prior rejections. The turnaround stands out because it f…
The WeekDrug Channels ↗
Informa Connect's Medicaid Drug Rebate Program Summit October 5-7, 2026 | Chicago, IL Drug Channels readers sa…
The WeekPharmaceutical Technology ↗
Innovent Biologics and Daiichi Sankyo have signed an exclusive agreement to commercialise Vanflyta, an oral ty…
The WeekBioPharma Dive ↗
Submission readiness extends beyond content. Early regulatory operations planning supports a compliant, high-q…
The WeekSTAT News ↗
China has tightened regulations on investigator-initiated trials, with consequences not just for Chinese resea…
The WeekFiercePharma ↗
Fierce Pharma is launching the weekly Oral GLP-1 Tracker, leveraging analysts' notes and IQVIA data to monitor…
The WeekFierceBiotech ↗
Two growing biotechs blasted through their IPO expectations Friday, with Blossom Hill Therapeutics and Latigo …
The WeekBriefing
FDA’s Aug. 6 update added a fresh set of first generic approvals for 2026. The mix spans hospital drugs, speci…
The WeekFiercePharma ↗
Injected weight loss drugs remain favored over newer oral treatments by a significant margin, with Eli Lilly's…
The WeekFierceBiotech ↗
Boston biotech Ensoma is doubling down on its lead gene therapy for a rare immune disease, laying off another …
The WeekBriefing
A STAT summary said Eli Lilly and Novo Nordisk persuaded a federal judge to dismiss an antitrust lawsuit by a …
The WeekSTAT News ↗
"To blame Fauci for not solving the origin of Covid-19 makes as much sense as blaming a detective in Washingto…
The WeekSTAT News ↗
From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmace…
The WeekBioPharma Dive ↗
Early indicators from a compassionate use plan led analysts to hike projections for daraxonrasib. Elsewhere, I…
The WeekPharmaVoice ↗
Big Pharmas won't get hit new levies on branded drugs; and aside from the megamerger rumors, BMS has had a rel…
The WeekPharmaVoice ↗
BMS is the latest major drugmaker to tap Nvidia for more computing power, betting that larger models and AI ag…
The WeekBioPharma Dive ↗
The company could rival Vertex and Lilly in the burgeoning market for non-opioid, ion-channel-blocking pain dr…
The WeekPharmaceutical Technology ↗
Alongside Alkeus, companies like Belite Bio, Ocugen and Nanoscope are aiming to secure a place on the Stargard…
The WeekFiercePharma ↗
The partnership marks Basuch + Lomb's foray into the digital and AI healthcare space.…
The WeekFierceBiotech ↗
PacBio has promoted an internal veteran to CEO after Christian Henry stepped down, tasking the new leader with…
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.